Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mattia Boeri

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Epidemiologia E Prevenzione|March 9, 2016
[Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test]Stefano Sestini, Mattia Boeri, Alfonso Marchianò, et al.
Molecules (Basel, Switzerland)|March 13, 2014
Assessment of circulating microRNAs in plasma of lung cancer patientsOrazio Fortunato, Mattia Boeri, Carla Verri, et al.
Journal of Visualized Experiments : Jove|November 21, 2017
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer ScreeningMavis Mensah, Cristina Borzi, Carla Verri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 24, 2021
miR-17 Epigenetic Modulation of LKB1 Expression in Tumor Cells Uncovers a New Group of Patients With Poor-Prognosis NSCLCCristina Borzi, Elisa Caiola, Monica Ganzinelli, et al.
Viruses|January 22, 2022
Timeline of SARS-CoV-2 Spread in Italy: Results from an Independent Serological RetestingEmanuele Montomoli, Giovanni Apolone, Alessandro Manenti, et al.
Ebiomedicine|October 2, 2015
Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk PopulationsJiangting Hu, Mattia Boeri, Gabriella Sozzi, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 30, 2025
Upfront blood microRNA test in LDCT-reluctant individuals: insights from the biomild trialGabriella Sozzi, Federica Sabia, Luigi Rolli, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 24, 2017
Inflammatory status and lung function predict mortality in lung cancer screening participantsUgo Pastorino, Daniele Morelli, Alfonso Marchianò, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancerMattia Boeri, Carla Verri, Davide Conte, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 16, 2022
Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer ScreeningOrazio Fortunato, Veronica Huber, Miriam Segale, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Epidemiologia E Prevenzione|March 9, 2016
[Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test]Stefano Sestini, Mattia Boeri, Alfonso Marchianò, et al.
Molecules (Basel, Switzerland)|March 13, 2014
Assessment of circulating microRNAs in plasma of lung cancer patientsOrazio Fortunato, Mattia Boeri, Carla Verri, et al.
Journal of Visualized Experiments : Jove|November 21, 2017
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer ScreeningMavis Mensah, Cristina Borzi, Carla Verri, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 24, 2021
miR-17 Epigenetic Modulation of LKB1 Expression in Tumor Cells Uncovers a New Group of Patients With Poor-Prognosis NSCLCCristina Borzi, Elisa Caiola, Monica Ganzinelli, et al.
Viruses|January 22, 2022
Timeline of SARS-CoV-2 Spread in Italy: Results from an Independent Serological RetestingEmanuele Montomoli, Giovanni Apolone, Alessandro Manenti, et al.
Ebiomedicine|October 2, 2015
Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk PopulationsJiangting Hu, Mattia Boeri, Gabriella Sozzi, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 30, 2025
Upfront blood microRNA test in LDCT-reluctant individuals: insights from the biomild trialGabriella Sozzi, Federica Sabia, Luigi Rolli, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 24, 2017
Inflammatory status and lung function predict mortality in lung cancer screening participantsUgo Pastorino, Daniele Morelli, Alfonso Marchianò, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancerMattia Boeri, Carla Verri, Davide Conte, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 16, 2022
Development of a Molecular Blood-Based Immune Signature Classifier as Biomarker for Risks Assessment in Lung Cancer ScreeningOrazio Fortunato, Veronica Huber, Miriam Segale, et al.
Pageof 6